These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1458781)

  • 1. Anti-dsDNA and Sm autoantibodies in systemic lupus erythematosus.
    Martínez-Cordero E; Martínez-Miranda E; Negrete-García MC; Padilla A; Aguilar León DE
    Clin Rheumatol; 1992 Sep; 11(3):341-5. PubMed ID: 1458781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.
    Eisenberg RA; Dyer K; Craven SY; Fuller CR; Yount WJ
    J Clin Invest; 1985 Apr; 75(4):1270-7. PubMed ID: 3872886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiotypic independency of anti-dsDNA and anti-Sm antibodies in SLE sera.
    Kubota T; Dang H; Takei M; Miyasaka N; Kanai Y; Talal N
    Clin Exp Rheumatol; 1989; 7(5):572-3. PubMed ID: 2591135
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-Sm: its predictive value in systemic lupus erythematosus.
    Janwityanuchit S; Verasertniyom O; Vanichapuntu M; Vatanasuk M
    Clin Rheumatol; 1993 Sep; 12(3):350-3. PubMed ID: 8258234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibodies in systemic lupus erythematosus.
    Fong KY; Boey ML; Howe HS; Feng PH
    Med J Malaysia; 1989 Jun; 44(2):151-5. PubMed ID: 2626124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and specificity of B-cell responses in lupus induced by Mycobacterium bovis in NOD/Lt mice.
    Horsfall AC; Howson R; Silveira P; Williams DG; Baxter AG
    Immunology; 1998 Sep; 95(1):8-17. PubMed ID: 9767451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
    Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
    J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of Sm antibodies and clinical symptoms in systemic lupus erythematosus].
    Serfling U; Brenke A; Ziegler H; Barthelmes H; Sönnichsen N
    Dermatol Monatsschr; 1988; 174(11):667-70. PubMed ID: 3264793
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M; Fritzler MJ; Blüthner M
    Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens.
    Field M; Williams DG; Charles P; Maini RN
    Ann Rheum Dis; 1988 Oct; 47(10):820-5. PubMed ID: 3143318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
    Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus.
    Fisher DE; Reeves WH; Wisniewolski R; Lahita RG; Chiorazzi N
    Arthritis Rheum; 1985 Dec; 28(12):1348-55. PubMed ID: 2417607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83-119 peptide in systemic lupus erythematosus and other autoimmune diseases.
    Jaekel HP; Klopsch T; Benkenstein B; Grobe N; Baldauf A; Schoessler W; Werle E
    J Autoimmun; 2001 Dec; 17(4):347-54. PubMed ID: 11771960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus.
    Al-Jabri AA; Al-Gahdani AK; Al-Shuaili I
    Rheumatol Int; 2009 Nov; 30(1):51-6. PubMed ID: 19360411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.
    Mahler M; Waka A; Hiepe F; Fritzler MJ
    Arthritis Res Ther; 2007; 9(4):R68. PubMed ID: 17640359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus.
    Gripenberg M; Teppo AM; Friman C
    Rheumatol Int; 1991; 11(4-5):209-13. PubMed ID: 1784890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic significance and diagnostic value of lupus autoantibodies.
    Tomer Y; Buskila D; Shoenfeld Y
    Int Arch Allergy Immunol; 1993; 100(4):293-306. PubMed ID: 8481649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
    Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
    Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activity.
    Williams RC; Malone CC; Silvestris F; Nickerson KG
    Clin Exp Rheumatol; 1997; 15(1):33-8. PubMed ID: 9093770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE.
    Ahlin E; Mathsson L; Eloranta ML; Jonsdottir T; Gunnarsson I; Rönnblom L; Rönnelid J
    Lupus; 2012 May; 21(6):586-95. PubMed ID: 22300829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.